Home › Geographic Atrophy › South Carolina
Geographic Atrophy clinical trials in South Carolina
4 studies for Geographic Atrophy are looking for participants at sites in South Carolina.
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Charleston Neuroscience Institute, LLC, Beaufort
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Sep 30, 2026 · NCT06635148A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
- Charleston Neuroscience Institute - Ladson- Site Number : 8400016, Ladson
- Charleston Neuroscience Institute - Ladson- Site Number : 8400046, Ladson
RecruitingPhase 1/2
Ages 60 and older · All sexes · Updated Sep 22, 2026 · NCT07215234A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Retina Consultants of Carolina, Greenville
- Charleston Neuroscience Institute LLC, Ladson
- Charleston Neuroscience Institute, LLC, Mt. Pleasant
- and 1 more
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Charleston Neuroscience Institute, Mt. Pleasant
- Palmetto Retina Center, West Columbia
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.